Kijoeng Nam
- Surgery top 10%
- Oncology top 10%
- Molecular Biology
- Urology top 5%
- Pulmonary and Respiratory Medicine
- Co-authors
- Ashish M. KamatEkta KapadiaHiroyuki NishiyamaTara L. FrenklDean F. BajorinRonald de WitEric A. SingerHo Kyung Seo
- Topics
- Bladder and Urothelial Cancer Treatments (19 papers)Cancer Immunotherapy and Biomarkers (12 papers)Cancer Research and Treatments (10 papers)
- Partner nations
- United StatesJapanCanada
In The Last Decade
Kijoeng Nam
21 papers receiving 594 citations
Hit Papers
Peers
Comparison fields: 5 of 53
- Surgery 526
- Oncology 238
- Molecular Biology 120
- Urology 100
- Pulmonary and Respiratory Medicine 81
Countries citing papers authored by Kijoeng Nam
This map shows the geographic impact of Kijoeng Nam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kijoeng Nam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kijoeng Nam more than expected).
Fields of papers citing papers by Kijoeng Nam
This network shows the impact of papers produced by Kijoeng Nam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kijoeng Nam. The network helps show where Kijoeng Nam may publish in the future.
Co-authorship network of co-authors of Kijoeng Nam
This figure shows the co-authorship network connecting the top 25 collaborators of Kijoeng Nam. A scholar is included among the top collaborators of Kijoeng Nam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kijoeng Nam. Kijoeng Nam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 studybreakdown → | 329 |
| 4 | 10 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 7 | |
| 8 | 23 | |
| 9 | 2 | |
| 10 | 59 | |
| 11 | 3 | |
| 12 | 4 | |
| 13 | 4 | |
| 14 | 80 | |
| 15 | 4 | |
| 16 | 21 | |
| 17 | 4 | |
| 18 | 13 | |
| 19 | 10 | |
| 20 | 12 |
About Kijoeng Nam
Kijoeng Nam is a scholar working on Biotechnology, Biochemistry and Oncology, having authored 22 papers that have together received 603 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (19 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Cancer Research and Treatments (10 papers). The work is most often cited by research in Urology (100 citations), Surgery (526 citations) and Oncology (238 citations). Kijoeng Nam has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Ashish M. Kamat, Ekta Kapadia, Hiroyuki Nishiyama, Tara L. Frenkl, Dean F. Bajorin, Ronald de Wit, Eric A. Singer, Ho Kyung Seo, Joost L. Boormans and Edward Uchio. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.